Assignee
ROSENTHAL ARNON
US·4 granted patents·4 pending applications·28 citations·filing 2005–2022
Top patents by PatentIndex Score
8 records- 0191US8540990B2Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the sameROSENTHAL ARNON·Filed 2006·Granted Sep 24, 2013·20 cites·38 claims
- 0280US8425905B2Antibodies directed against amyloid-beta peptide and methods using sameROSENTHAL ARNON·Filed 2012·Granted Apr 23, 2013·3 cites·18 claims
- 0380US2024309097A2Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryROSENTHAL ARNON·Filed 2022·Application pending·0 cites
- 0479US8268593B2Polynucleotides encoding antibodies directed against amyloid-beta peptideROSENTHAL ARNON·Filed 2010·Granted Sep 18, 2012·3 cites·35 claims
- 0576US8398978B2Antibodies directed against amyloid-beta peptide and methods using sameROSENTHAL ARNON·Filed 2010·Granted Mar 19, 2013·2 cites·19 claims
- 0668US2007160616A1Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereofROSENTHAL ARNON·Filed 2007·Application pending·0 cites
- 0764US2011287014A1Antibodies directed against calcium channel subunit alpha2/delta and methods using sameROSENTHAL ARNON·Filed 2009·Application pending·0 cites
- 0845US2005209148A1Methods of treating obesity or diabetes using NT-4/5ROSENTHAL ARNON·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →